VM is a separate disease entity with a genetic predisposition to recurrent dizziness or vertigo, with or without headache [23]. When presented with positional vertigo, VM and BPPV are difficult to distinguish. The difference lies in the atypical nystagmus of VM, which is usually not aligned with a single semicircular canal, while the nystagmus of BPPV induced by positional testing is synchronised with the symptoms and has a characteristic short duration, brief latency, and fatigability [2, 24]. VM and BRV may also show spontaneous vertigo, similar to MD. The auditory symptoms of VM and BRV are mild, whereas the hearing loss of MD patients is gradually aggravated with disease progression [16]. When the duration of spontaneous vertigo in VM or BRV is less than one minute, it can be similar to VP. VP is caused by vascular compression of the vestibular nerve, with attacks ranging from 30 times a day to several times a year, without headache. Carbamazepine is an effective treatment for VP [18]. However, the selected VM patients in this study were effectively treated with flunarizine, which increased the reliability of VM diagnosis. Since the subjects were all older than 18 years, the possibility of BPV in children was excluded.
Common paroxysmal vertigo can be categorised based on aetiology: central and peripheral aetiologies. The most common central causes are VM and transient ischemic attack, and the common peripheral causes are BPPV, MD, and VP. However, the classification of these four diseases does not cover all paroxysmal vertigo. Those with unknown causes of recurrent vertigo are classified as BRV, with a high incidence in the clinic. The BRV selected in previous clinical studies did not rule out a history of migraine and migraine-related symptoms, so a considerable number of BRV may have met the diagnostic criteria for VM [6, 7]. To avoid confusion, the selected BRV in this study only showed paroxysmal vertigo, that is, pure BRV. The selected VM patients without headache could be differentiated from pure BRV by its migraine characteristics, such as photophobia, phonophobia, or visual aura. A recent study reported for the first time a group of patients with paroxysmal vertigo with interictal headshaking nystagmus (HSN) [15]. The authors believe central lesions lead to a prolonged time constant, strong HSN, and perverted nystagmus through activated and asymmetric central velocity storage mechanisms. Our results demonstrated that BRV had a significantly higher proportion of RLS than peripheral vertigo diseases such as MD, BPPV, and VP. Although there were no central symptoms of photophobia, phonophobia, or visual aura, we speculate that pure BRV may be central vertigo without these central symptoms and is worthy of further study and discussion.
There is a dose-effect relationship between PFO and migraine. Larger PFO, permanent PFO, and anatomical variation of PFO can aggravate RLS, which is associated with migraine attacks [11]. Meanwhile, PFO is more associated with MA than MoA. The correlation between RLS and migraines does not imply causality, and the mechanism between the two is not clear. The possible mechanism is that vasoactive substances and microemboli from the venous system directly enter systemic circulation without passing through the pulmonary circulation, causing transient hypoperfusion in the area supplied by the cerebral arteries or cortical spreading depression, activating the trigeminal neurovascular system, and causing migraine attacks [25, 26]. The initiating mechanism of VM is considered to be similar to migraine because RLS not only induces migraine but also causes vertigo by inducing plasma extravasation in the inner ear [27]. Microemboli or vasoactive substances may induce CSD and activate the caudal parabrachial nucleus, which receives both trigeminal receptors and vestibular nerve afferents, resulting in simultaneous vestibular symptoms and migraine symptoms [1, 28]. Therefore, we speculate that RLS may be involved in the pathogenesis of VM.
Many studies have found that BRV is highly correlated with migraine or VM and may have similar pathogenesis [6, 29, 30]. However, some studies have suggested otherwise [31]. Whether BRV is a separate entity is still controversial, but a considerable number of BRVs are free from inner ear dysfunction and migraine and therefore do not develop into MD and VM, suggesting that there may be different mechanisms in this aspect of BRV [7]. This study showed that the proportion of RLS in patients with BRV, VM, and migraine was significantly higher than those with peripheral vertigo disease, suggesting that RLS might play an important role in the pathogenesis of BRV, VM, and migraine. The current literature remains discordant as to whether a linkage exists between RLS grade and the degree of vertigo. We found that the DHI score increased with an increase in the RLS shunt, suggesting that RLS plays an important role in the degree of vertigo and quality of life of vestibular disorders. The proportions of RLS in patients with BRV and VM were similar to those of migraine, suggesting that the above-mentioned mechanisms may share some features in the pathogenesis of migraine. When the related mechanism of migraine only involves the vestibular system, it can manifest as pure BRV, whereas when the vestibular system and trigeminal neurovascular system are simultaneously involved, it can manifest as VM. When only the trigeminal neurovascular system is involved, the symptoms may include migraine, suggesting that BRV and VM may be subtypes or equivalents of migraine. VM and pure BRV can be unified in the migraine category. In this study, the RLS of patients with BPPV and VP was significantly lower than that of patients with migraine, suggesting that RLS was not involved in the pathogenesis of these peripheral vertigo diseases. RLS can play a role in the differential diagnosis of paroxysmal vertigo. In the future, for refractory VM and BRV patients, the evaluation of RLS and the intervention and treatment of RLS are worthy of further exploration.
Previous literature has predominantly defined the duration of BRV as more than 1 min or even more than 5 min, mainly distinguishing it from BPPV and VP, which are less than 1 min. There are few reports of a BRV of less than 1 min. A previous study found six cases of BRV with migraine that were less than 1 min, and only one case of BRV without migraine was less than 1 minute [6]. In clinical practice, there are truly spontaneous recurrent vertigoes lasting less than 1 min. These patients do not meet the diagnostic criteria for BPPV and VP, and they do not meet the diagnostic criteria for VM. The duration of BRV was not specifically limited in this study. The proportion of RLS between the patients with BRV lasting less and more than 1 minute was similar, and significantly higher than that of VP and BPPV. Thus, strictly defining the duration for diagnosis of BRV may be debatable, and the evaluation of RLS might help to provide a reference for BRV diagnosis.
Due to the low probability of migraine onset after 50 years of age, patients with headache-free BRV after the age of 50 have a very low probability of developing VM, while patients with BRV before the age of 50 still have the possibility of progressing to VM. Therefore, we regarded age 50 as the threshold for the intragroup (subgroup) analysis of BRV. The results showed that the proportion of RLS in patients with BRV before and after 50 years of age was not significantly different and was similar to that of migraine. This may be related to the fact that BRV rarely evolves into VM [32].
With the insight into VM and the gradual clarification of its concept, there is an overlap between the classical concepts of BRV and VM, leading to ambiguity in the concept of BRV; thus, its effective use in clinics is difficult. In this study, pure BRV was proposed for the first time, and it can be effectively distinguished from VM in the absence of migraine-related characteristics. Pure BRV can also be effectively distinguished from peripheral vertigo, such as MD. Therefore, the concept of pure BRV is helpful for clinicians to further study the mechanism, clinical characteristics, and prognosis of the disease. The concept and classification of VM and BRV in the future are worthy of further discussion.
There are several limitations to our study. First, because TIA, persistent postural-perceptual dizziness, epileptic vertigo, and paroxysmal ataxia were excluded from the selection criteria of BRV in this study, these paroxysmal vertigoes were not compared with RLS. Second, BRV with HSN has been reported to originate from the central nervous system, and in this study, BRV was not subdivided according to whether it was associated with HSN.